Tags

Type your tag names separated by a space and hit enter

The year's new drugs and biologics 2020.
Drugs Today (Barc). 2021 Feb; 57(2):101-177.DT

Abstract

2020 will go down in history as a year marked in every respect by the emergence and astonishingly rapid spread of the first major global viral pandemic in a century. It seems like nearly every event or story of the year was influenced in some way by COVID-19, and in that respect, the year ended on a high note with the authorization for emergency use of the first vaccines to prevent SARS-CoV-2 infection and drugs to treat COVID-19. Despite the pandemic's dominance of the 2020 headlines, productivity was at a record high level across all therapeutic areas, as seen by the number of products in this year's review: approximately 50% more than the previous year. Notable achievements include the launch of the first treatment for hepatitis D; regulatory decisions on a suite of biologics for the prevention and treatment of Ebola virus disease, fruit of the 2016-2018 outbreak in the Democratic Republic of Congo; the approval of the first-ever drug to treat Hutchinson-Gilford progeria syndrome, a rare genetic disorder that leads to premature aging; the first treatment developed specifically for thyroid eye disease, also known as Graves' ophthalmopathy; the first nonhormonal, on-demand, vaginal pH-regulating contraceptive; and the first oral allergen immunotherapy for peanut allergy.

Authors+Show Affiliations

Clarivate, Barcelona, Spain. ann.graul@clarivate.com.Clarivate, Barcelona, Spain.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33656016

Citation

Graul, A I., and L A. Sorbera. "The Year's New Drugs and Biologics 2020." Drugs of Today (Barcelona, Spain : 1998), vol. 57, no. 2, 2021, pp. 101-177.
Graul AI, Sorbera LA. The year's new drugs and biologics 2020. Drugs Today (Barc). 2021;57(2):101-177.
Graul, A. I., & Sorbera, L. A. (2021). The year's new drugs and biologics 2020. Drugs of Today (Barcelona, Spain : 1998), 57(2), 101-177. https://doi.org/10.1358/dot.2021.57.2.3275929
Graul AI, Sorbera LA. The Year's New Drugs and Biologics 2020. Drugs Today (Barc). 2021;57(2):101-177. PubMed PMID: 33656016.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The year's new drugs and biologics 2020. AU - Graul,A I, AU - Sorbera,L A, PY - 2021/3/3/entrez PY - 2021/3/4/pubmed PY - 2021/3/5/medline KW - Accelerated approvals KW - Authorizations for emergency use KW - COVID-19 KW - First-in-class drugs KW - Line extensions KW - New combinations KW - New drug approvals KW - New drug launches KW - New formulations KW - New indications KW - Orphan drugs SP - 101 EP - 177 JF - Drugs of today (Barcelona, Spain : 1998) JO - Drugs Today (Barc) VL - 57 IS - 2 N2 - 2020 will go down in history as a year marked in every respect by the emergence and astonishingly rapid spread of the first major global viral pandemic in a century. It seems like nearly every event or story of the year was influenced in some way by COVID-19, and in that respect, the year ended on a high note with the authorization for emergency use of the first vaccines to prevent SARS-CoV-2 infection and drugs to treat COVID-19. Despite the pandemic's dominance of the 2020 headlines, productivity was at a record high level across all therapeutic areas, as seen by the number of products in this year's review: approximately 50% more than the previous year. Notable achievements include the launch of the first treatment for hepatitis D; regulatory decisions on a suite of biologics for the prevention and treatment of Ebola virus disease, fruit of the 2016-2018 outbreak in the Democratic Republic of Congo; the approval of the first-ever drug to treat Hutchinson-Gilford progeria syndrome, a rare genetic disorder that leads to premature aging; the first treatment developed specifically for thyroid eye disease, also known as Graves' ophthalmopathy; the first nonhormonal, on-demand, vaginal pH-regulating contraceptive; and the first oral allergen immunotherapy for peanut allergy. SN - 1699-3993 UR - https://www.unboundmedicine.com/medline/citation/33656016/The_year's_new_drugs_and_biologics_2020. L2 - http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=3275929 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.